GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (STU:73M) » Definitions » Selling and Marketing Expense

MedAvail Holdings (STU:73M) Selling and Marketing Expense : €0.34 Mil (TTM As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is MedAvail Holdings Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. MedAvail Holdings's Selling and Marketing Expense for the three months ended in Jun. 2023 was €0.01 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 was €0.34 Mil.

MedAvail Holdings Selling and Marketing Expense Historical Data

The historical data trend for MedAvail Holdings's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAvail Holdings Selling and Marketing Expense Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Selling and Marketing Expense
2.95 0.46 0.86 0.68

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.17 0.14 0.02 0.01

MedAvail Holdings Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of MedAvail Holdings's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

MedAvail Holdings (STU:73M) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAvail Holdings Inc (STU:73M) » Definitions » Selling and Marketing Expense
Comparable Companies
HEWA BIMI MEDS CJJD SSY RADCQ LFLY RXMD WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 TSE:3391 JSE:CLS TSE:3141 TSE:9989
Traded in Other Exchanges
MDVL:USA
Address
4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
Website
https://www.medavail.com
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.

MedAvail Holdings (STU:73M) Headlines

No Headlines